Key facts
- This page summarizes Preeta Chidambaran's Form 3 filing for Arrowroot Acquisition Corp. (AILEQ).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Apr 2024, 21:39.
Preeta Chidambaran - 16 Apr 2024 Form 3 Insider Report for Arrowroot Acquisition Corp. (AILEQ)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- AILEQ
- Reported as of
- 16 Apr 2024
- Net transaction value
- $0
- Reporting owner signature
- By /s/ David Samuels, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Preeta Chidambaran filed Form 3 for Arrowroot Acquisition Corp. (AILEQ) on 18 Apr 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AILE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,799,432
- Date
- 16 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
AILE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 77,964,895
- Date
- 16 Apr 2024
- Ownership
- By Spouse
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 4,561,014 shares of restricted stock which vest in 10 equal annual installments beginning on April 16, 2025. Under the terms of the relevant restricted stock purchase agreement, the relevant reported shares of restricted stock may not be transferred without the consent of the Issuer and are subject to a repurchase right in favor of the Issuer.
Footnote F2
Includes 27,590,898 shares of restricted stock which vest in 10 equal annual installments beginning on April 16, 2025. Under the terms of the relevant restricted stock purchase agreement, the relevant reported shares of restricted stock may not be transferred without the consent of the Issuer and are subject to a repurchase right in favor of the Issuer.
Footnote F3
The securities are held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.